Evolution of transfusion risks over a 15-year period (1987-2002);Évolution des risques transfusionnels en 15 ans (1987-2002)

Annales Francaises d'Anesthesie et de Reanimation

Volumn 23, Issue 11, 2004, Pages 1102-1106

  Rouger, P ^a  

^a INSERM   (France)

Author keywords

Blood products; Blood safety; Blood transfusion; Gestion des risques; Haemovigilance; H movigilance; Produits sanguins; Risk management; S curit transfusionnelle; Transfusion sanguine

Indexed keywords

ARTICLE; BLOOD TRANSFUSION REACTION; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; PREDICTION; RISK ASSESSMENT; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; ECONOMICS; FRANCE; HEALTH SURVEY; RISK FACTOR;

BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; EUROPE; FRANCE; HIV INFECTIONS; HUMANS; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS;

EID: 10044252261     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2004.10.015     Document Type: Article

References (15)

1. re Ed 2000 John Libbey Eurotext Paris
2. Établissement Fraņais du Sang, Paris Rapport d'activit́ 2002
3. re Ed 2003 Masson Paris
4. Agence Fraņaise de Ścurit́ Sanitaire des Produits de Sant́ H́movigilance Rapport 2002 Paris
5. P. Rouger Blood transfusion in Europe: a white book 2005 Elsevier Paris (in press)
6. J.C. Faber L'h́movigilance en Europe Transfus. Clin. Biol. 7 2000 5 8
7. P. Rouger Transfusion medicine in Europe Transfus Clin. Biol. 11 2004 11 14
8. J.C. Faber Work of the European Haemovigilance Network (EHN) Transfus Clin. Biol. 11 2004 2 10
9. P. Rouger, F. Noizat-Pirenne, and P.Y. Le Pennec Haemovigilance and transfusion safety in France Vox Sang 78 2000 287 289
10. P. Rouger L'Europe de la Transfusion Sanguine Transfus Clin. Biol. 10 2003 126 130
11. J.C. Faber Haemovigilance around the world Vox Sang 83 2002 71 76
12. Directive 2002/98/CE du Parlement européen et du Conseil, établissant les normes de qualité et de sécurité pour la collecte, le contrôle, la transformation, la conservation et la distribution du sang humain et des composants sanguins, et modifiant la Directive 2001/83/CE ; J.O. CE 08.02.2003.
13. A.M. Tissier, P.Y. Le Pennec, E. Hergon, and P. Rouger Les ŕactions immunoh́molytiques transfusionnelles. Analyses, risques et pŕvention Transfus. Clin. Biol. 3 1996 167 180
14. P. Rouger, P.Y. Le Pennec, and F. Noizat-Pirenne Analyse des risques immunologiques en transfusion sanguine Transfus. Clin. Biol. 7 2000 9 14
15. B. Custer Economic analyses of blood safety and transfusion medicine intervention: a systematic review Transfus Med. Rev. 18 2004 127 143